Results 201 to 210 of about 440,067 (322)

Synthesis and Evaluation of Fluorinated Peptidomimetics Enabling the Development of 18F‐Labeled Radioligands Targeting Muscarinic Acetylcholine Receptor Subtype M3

ChemMedChem, EarlyView.
Fluorinated peptidomimetics targeting muscarinic acetylcholine receptor subtype M3: Fluorinated peptidomimetic compounds based on a β‐alanine‐glycine scaffold, with lead compound 24 demonstrating high M3 selectivity and submicromolar potency. The first M3‐selective positron emission tomography radioligand, [18F]24, is synthesized and will be evaluated ...
Miguel A. Herrera‐Rueda, Maxwell A. Boateng, Melinda Wuest, Frederick G. West, Frank Wuest   +4 more
wiley   +1 more source

Design of a Mobile and Electromagnetic Emissions-Compliant Brain Positron Emission Tomography (PET) Scanner. [PDF]

Sensors (Basel)
Fuentes C, Béguin M, Commichau V, Flock J, Lomax AJ, Makkar S, McNamara K, Prior JO, Ritzer C, Winterhalter C, Dissertori G.   +10 more
europepmc   +1 more source

Positron Emission Tomographic Measurement of Acute Hemodynamic Changes in Primate Middle Cerebral Artery Occlusion

, 1992
Hiroshi Tenjin, Satoshi Ueda, Norihiko Mizukawa, Yoshio Imahori, Akihiko HINO, Yoshio Ohmori, Kiyoshi YASUKOCHI, Hisamitsu Nakahashi, Kazuo Wakita, Hitoshi Horii, Ryou Fujii   +10 more
openalex   +2 more sources

Explorations into Peptide Nucleic Acid Contrast Agents as Emerging Scaffolds for Breakthrough Solutions in Medical Imaging and Diagnosis

ACS Omega, 2021
Rüdiger M. Exner, Stephen J. Paisey, James E. Redman, Sofia I. Pascu   +3 more
doaj   +1 more source

Metabolic parameters in F-fluorodeoxyglucose positron emission tomography/computed tomography for treatment response in colorectal carcinoma. [PDF]

Rev Assoc Med Bras (1992)
Güzel F, Tuzcu ŞA, Taşdemir B.
europepmc   +1 more source

Effects of Percent Thresholding on the Extraction of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data

, 1991
David A. Rottenberg, James R. Moeller, Stephen C. Strother, Vijay Dhawan, M. L. Sergi   +4 more
openalex   +1 more source

Positron Emission Tomography of Monoclonal Antibodies [PDF]

, 1993
Kalevi Kairemo
openalex   +1 more source

The Pathway to Proof‐of‐Concept for BNC210, a Negative Allosteric Modulator of the Alpha‐7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease

Clinical Pharmacology in Drug Development, EarlyView.
Abstract BNC210 is an investigational small molecule selective negative allosteric modulator of the alpha‐7 nicotinic acetylcholine receptor (α7 nAChR). It is an anxiolytic compound with a novel mechanism of action. In a series of Phase 1 clinical trials in healthy volunteers, psychometric test batteries showed that BNC210 did not cause attention ...
Paul Rolan, Elizabeth Doolin, Dharam Paul, Julia Crossman, Michael Odontiadis, Philippe Danjou, Mark Smith, Spyros Papapetropoulos   +7 more
wiley   +1 more source

Towards P2X4 Positron Emission Tomography Tracing. [PDF]

J Med Chem
Federico S.
europepmc   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source